| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0092 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |